Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Immunome Inc (NASDAQ: IMNM) closed at $8.47 down -8.98% from its previous closing price of $9.3. In other words, the price has decreased by -$8.98 from its previous closing price. On the day, 1.18 million shares were traded. IMNM stock price reached its highest trading level at $9.3423 during the session, while it also had its lowest trading level at $8.46.
Ratios:
For a deeper understanding of Immunome Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $27 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 03 ’25 when BIENAIME JEAN JACQUES bought 5,000 shares for $9.38 per share. The transaction valued at 46,900 led to the insider holds 36,415 shares of the business.
BIENAIME JEAN JACQUES bought 7,800 shares of IMNM for $60,684 on Mar 25 ’25. The Director now owns 31,415 shares after completing the transaction at $7.78 per share. On Mar 26 ’25, another insider, SIEGALL CLAY B, who serves as the President and CEO of the company, bought 137,100 shares for $7.29 each. As a result, the insider paid 999,459 and bolstered with 806,736 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 736559168 and an Enterprise Value of 496661664. For the stock, the TTM Price-to-Sale (P/S) ratio is 67.33 while its Price-to-Book (P/B) ratio in mrq is 2.40. Its current Enterprise Value per Revenue stands at 45.407 whereas that against EBITDA is -2.826.
Stock Price History:
The Beta on a monthly basis for IMNM is 1.93, which has changed by -0.30156767 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $16.81, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is -1.77%, while the 200-Day Moving Average is calculated to be -17.80%.
Shares Statistics:
For the past three months, IMNM has traded an average of 1.14M shares per day and 1238330 over the past ten days. A total of 86.96M shares are outstanding, with a floating share count of 76.80M. Insiders hold about 11.74% of the company’s shares, while institutions hold 82.19% stake in the company. Shares short for IMNM as of 1749772800 were 12517420 with a Short Ratio of 10.98, compared to 1747267200 on 12720847. Therefore, it implies a Short% of Shares Outstanding of 12517420 and a Short% of Float of 15.03.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
